loading page

A single centre's experience of 23 cases of total rhinectomy for the treatment of nasal vestibule squamous cell carcinoma.
  • +4
  • Emilien Chabrillac,
  • Ashish Talawdekar,
  • Satya Garikipati,
  • Iain Varley,
  • Sara Sionis,
  • Nigel Beasley,
  • Richard Jackson
Emilien Chabrillac
Cancer University Institute Toulouse Oncopole Department of Surgery

Corresponding Author:[email protected]

Author Profile
Ashish Talawdekar
Sheffield Teaching Hospitals NHS Foundation Trust
Author Profile
Satya Garikipati
Weston Park Hospital
Author Profile
Iain Varley
Sheffield Teaching Hospitals NHS Foundation Trust
Author Profile
Sara Sionis
Sheffield Teaching Hospitals NHS Foundation Trust
Author Profile
Nigel Beasley
Sheffield Teaching Hospitals NHS Foundation Trust
Author Profile
Richard Jackson
Sheffield Teaching Hospitals NHS Foundation Trust
Author Profile

Abstract

Objectives: This study aims to analyse the management outcomes of total rhinectomy (TR) for nasal squamous cell carcinomas (SCCs) involving the vestibule, and to identify prognostic factors for disease recurrence. Design: A retrospective single centre study was conducted between September 2003 and February 2021 including all patients who underwent a TR for a SCC involving the nasal vestibule. Results: 23 patients were included in the study. Tumours originated from the septum (n=12), vestibule (n=8) or skin (n=3). Six TR (26.1%) were salvage procedures, after primary radiotherapy or nose-preserving rhinectomy. Seven patients had a concurrent neck dissection and 17 patients (73.9%) received adjuvant treatment (14 patients had radiotherapy and 3 had chemoradiotherapy). After a median follow-up of 32 months, six patients (26.1%) presented with tumour recurrence. Three patients (13%) had nodal-only recurrence. The estimated 5-year overall survival, disease-free survival and disease-specific survival was 67.5%, 66.3% and 80.7% respectively. Positive excision margins were a predictive factor for tumour recurrence after TR (p=0.0401). Conclusions: For nasal vestibule SCCs not amenable to limited surgical resection, TR along with adjuvant radiotherapy provide good oncological outcomes and should be considered the main treatment option.